New evidence
Meta-analysis links vitamin D to a large improvement in how the pancreas responds to glucose, but only in people with diabetes or prediabetes
This pooled analysis of six studies adds moderate-strength evidence that vitamin D may meaningfully improve insulin secretion and glycemic control in those already struggling with blood sugar — but it doesn't yet tell us who should take what dose, and the effect hasn't been tested in healthy people.
A systematic review of six trials found that vitamin D supplementation was tied to a large increase in HOMA-β, a measure of how well the pancreas produces insulin in response to glucose. The same analysis also saw drops in HbA1c and LDL cholesterol in diabetic and prediabetic patients, though most individual studies had mixed effect sizes, so the average finding should be interpreted cautiously.
Where this fits in the evidence
Pillser has synthesized 9 studies on Vitamin D for Improved Insulin Sensitivity — overall evidence strength: Moderate.
Across 9 studies, 6 reported beneficial effects on insulin sensitivity, though effect sizes were predominantly small (3 of 6 beneficial studies) and the highest-quality evidence (a systematic review of 1063 women with PCOS) found only modest, non-significant improvements. Median study duration was 63 days (9 weeks), and the most commonly reported dose range was 1000–4000 IU/day. Effects appeared more consistent in populations with vitamin D deficiency or metabolic conditions (e.g., PCOS, gestational diabetes, obesity, diabetes/prediabetes).
The study
- Meta-Analysis
- 2025-09-18
- Nutrients
- PubMed: 41010515
- DOI: 10.3390/nu17182991
- Full study breakdown →
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.